The impact of coronavirus disease 2019 (COVID-19) on the functioning of the brain is progressively being underscored as societies accumulate both scientific and experiential knowledge of living through the illness. Lee
et al. [
1] reported findings of multifocal microvascular brain injuries in a postmortem study of brain tissue from patients with COVID-19. In a sample of 125 patients, Varatharaj
et al. [
2] reported that a large proportion (62%) of patients presented with a cerebrovascular event and 31% presented with altered mental status, of which 23% had unspecified encephalopathy and 18% had encephalitis. In their study, as many as 59% of the patients who manifested altered mental status fulfilled the diagnostic criteria for psychiatric diagnoses. It has been proposed that anxiety is at the core of the predisposing, precipitating, and perpetuating factors underlying various neuropsychiatric abnormalities (such as agitation, disorganization, paranoid ideation, and auditory hallucinations) detected in patients with COVID-19 [
3]. Metabolic disturbances and white matter damage in the brain due to hypoxia were detected in a recent study by Rapalino
et al. [
4]. A variety of studies (see [
5] for a detailed review) have shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may present with various neurological and central nervous system (CNS) symptom manifestations. Among these are headache and confusion, and even seizures or encephalitis. Ardila and Lahiri [
6] specifically anticipated the occurrence of executive dysfunction as a part of the neurological impairments due to the infection, in both the acute phase and the long run. Lima
et al. [
5] proposed that the virus may invade the CNS through various pathways within dual (hematogenous and neuronal) routes. In this transmission, the olfactory pathway in particular is thought to play a significant role. The findings of Zhou
et al. [
7] highlighted the parallel organization of the olfactory system and indicated that the anterior olfactory nucleus has the strongest unique connectivity with the orbitofrontal cortex. Other smaller connectivity clusters were found to reside in the left inferior temporal gyrus, bilateral anterior temporal gyri, the bilateral anterior insula and the mammillary bodies, and retromammillary commissure. Furthermore, their work revealed that, compared with other sensory systems, the olfactory networks reach a broader set of cortical targets (largely situated in the frontal and temporal piriform cortices) at an earlier stage of information processing. This functional specificity along with the strong frontotemporal anatomical brain connectivity of the olfactory system is likely to underlie the key role of the latter for the invasion of the viral infection into the CNS. Contributing factors to the wide scope of neurofunctional abnormalities brought about by the virus could be its neuroinvasive, neurotropic, and neurovirulent nature [
5] and the multiple pathways through which it attacks the CNS. In their recent study, conducted with COVID-19 patients during acute inpatient rehabilitation stage prior to discharge, Jaywant
et al. [
8] found that attention and executive functions were most affected. This finding lends support to the view put forward by Snyder
et al. [
9] that executive control impairments are transdiagnostic and inherent to a broad spectrum of clinical conditions.
The evaluation of neuropsychological and psychological functions, while the person is in the acute stage the illness, presents a methodological challenge. Firstly, the primary focus in the ongoing treatment is preservation of life and ensuring the patient’s survival. Secondly, the patient’s overall health status is likely to not permit them to participate in the assessment process. Thirdly, the administration of the neuropsychological tests typically requires face-to-face interaction, which is not possible given the risk of contamination. Consequently, systematic data collection using psychometric tests is not feasible. Introspective inquiry capturing the first-person experience of trained psychologists and neuropsychologists who had COVID-19 is considered methodologically relevant and appropriate, particularly in view of the unfeasibility of applying psychometric methods for assessing the impairments emerging as the infectious process evolves.
The aim of the present investigation was to document the first-person account of the range of neuropsychological and psychological symptoms experienced by the author while undergoing COVID-19. Her reflections on the presenting symptoms and the formulation on their hypothesized generative mechanisms are informed by her extensive professional experience in conducting neuropsychological and psychological assessments and providing psychotherapeutic support to patients with various brain dysfunctions, including tumors, traumatic brain injuries (TBI), degenerative disorders such as Parkinson’s disease (PD), developmental disorders, epilepsy, functional neurological disorder (FND), and psychogenetic non-epileptic seizures (PNES).